Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition

References

• SanvicensNMarcoMPMultifunctional nanoparticles – properties and prospects for their use in human medicineTrends Biotechnol200826842543318514941
   PubMed Web of Science ®Google Scholar
• YooDLeeJHShinTHCheonJTheranostic magnetic nanoparticlesAcc Chem Res2011441086387421823593
   PubMed Web of Science ®Google Scholar
• FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
   PubMed Web of Science ®Google Scholar
• DobrovolskaiaMAAggarwalPHallJBMcNeilSEPreclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistributionMol Pharm20085448749518510338
   PubMed Web of Science ®Google Scholar
• FischerHCChanWCNanotoxicity: the growing need for in vivo studyCurr Opin Biotechnol200718656557118160274
   PubMed Web of Science ®Google Scholar
• Dell’OrcoDLundqvistMOslakovicCCedervallTLinseSModeling the time evolution of the nanoparticle-protein corona in a body fluidPLoS One201056e1094920532175
   PubMed Web of Science ®Google Scholar
• CasalsEPfallerTDuschlAOostinghGJPuntesVTime evolution of the nanoparticle protein coronaACS Nano2010473623363220553005
   PubMed Web of Science ®Google Scholar
• CapriottiALCavaliereCFogliaPDevelopment of an analytical strategy for the identification of potential bioactive peptides generated by in vitro tryptic digestion of fish muscle proteinsAnal Bioanal Chem20147711–12755769
   Google Scholar
• CedervallTLynchIFoyMDetailed identification of plasma proteins adsorbed on copolymer nanoparticlesAngew Chem Int Ed Engl200746305754575617591736
   PubMed Web of Science ®Google Scholar
• LundqvistMStiglerJCedervallTThe evolution of the protein corona around nanoparticles: a test studyACS Nano2011597503750921861491
   PubMed Web of Science ®Google Scholar
• CapriottiALCaraccioloGCavaliereCDo plasma proteins distinguish between liposomes of varying charge density?J Proteomics20127561924193222266103
   PubMed Web of Science ®Google Scholar
• NelAEMadlerLVelegolDUnderstanding biophysicochemical interactions at the nano-bio interfaceNat Mater20098754355719525947
   PubMed Web of Science ®Google Scholar
• MahmoudiMLynchIEjtehadiMRMonopoliMPBombelliFBLaurentSProtein-nanoparticle interactions: opportunities and challengesChem Rev201111195610563721688848
   PubMed Web of Science ®Google Scholar
• LundqvistMStiglerJEliaGLynchICedervallTDawsonKANanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProc Natl Acad Sci U S A200810538142651427018809927
   PubMed Web of Science ®Google Scholar
• TenzerSDocterDRosfaSNanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysisACS Nano2011597155716721866933
   PubMed Web of Science ®Google Scholar
• LundqvistMSethsonIJonssonBHProtein adsorption onto silica nanoparticles: conformational changes depend on the particles’ curvature and the protein stabilityLangmuir20042024106391064715544396
   PubMed Web of Science ®Google Scholar
• LindKKresseMMullerRHComparison of protein adsorption patterns onto differently charged hydrophilic superparamagnetic iron oxide particles obtained in vitro and ex vivoElectrophoresis200122163514352111669535
   PubMed Web of Science ®Google Scholar
• MonopoliMPAbergCSalvatiADawsonKABiomolecular coronas provide the biological identity of nanosized materialsNat Nanotechnol201271277978623212421
   PubMed Web of Science ®Google Scholar
• AggarwalPHallJBMcLelandCBDobrovolskaiaMAMcNeilSENanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdv Drug Deliv Rev200961642843719376175
   PubMed Web of Science ®Google Scholar
• IvanovYDGovorunVMBykovVAArchakovAINanotechnologies in proteomicsProteomics2006651399141416447155
   PubMedGoogle Scholar
• JohnsonCJZhukovskyNCassAENagyJMProteomics, nanotechnology and molecular diagnosticsProteomics20088471573018297650
   PubMedGoogle Scholar
• RaySChandraHSrivastavaSNanotechniques in proteomics: current status, promises and challengesBiosens Bioelectron201025112389240120451366
   PubMedGoogle Scholar
• AndersonNLAndersonNGThe human plasma proteome: history, character, and diagnostic prospectsMol Cell Proteomics200211184586712488461
   PubMed Web of Science ®Google Scholar
• QianWJJacobsJMLiuTCampDG2ndSmithRDAdvances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applicationsMol Cell Proteomics20065101727174416887931
   PubMed Web of Science ®Google Scholar
• RaySReddyPJChoudharySRaghuDSrivastavaSEmerging nanoproteomics approaches for disease biomarker detection: a current perspectiveJ Proteomics201174122660268121596164
   PubMedGoogle Scholar
• LuchiniAFredoliniCEspinaBHNanoparticle technology: addressing the fundamental roadblocks to protein biomarker discoveryCurr Mol Med201010213314120196732
   PubMed Web of Science ®Google Scholar
• GodinBSakamotoJHSerdaREGrattoniABouamraniAFerrariMEmerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseasesTrends Pharmacol Sci201031519920520172613
   PubMed Web of Science ®Google Scholar
• CapriottiALCarusoGCavaliereCPiovesanaSSamperiRLaganaAComparison of three different enrichment strategies for serum low molecular weight protein identification using shotgun proteomics approachAnal Chim Acta2012740586522840651
   PubMed Web of Science ®Google Scholar
• FredoliniCMeaniFLuchiniAInvestigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technologyAAPS J201012450451820549403
   PubMed Web of Science ®Google Scholar
• VillanuevaJPhilipJEntenbergDSerum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometryAnal Chem20047661560157015018552
   PubMed Web of Science ®Google Scholar
• XiLJunjianZYuminLYunwenLHongbinWSerum biomarkers of vascular cognitive impairment evaluated by bead-based proteomic technologyNeurosci Lett2009463161119631719
   PubMedGoogle Scholar
• PasiniEMMannMThomasAWRed blood cell proteomicsTransfus Clin Biol201017315116420655788
   PubMedGoogle Scholar
• GoodmanSRKurdiaAAmmannLKakhniashviliDDaescuOThe human red blood cell proteome and interactomeExp Biol Med20072321113911408
   PubMed Web of Science ®Google Scholar
• WeatherallDJProvanABRed cells I: inherited anaemiasLancet200035592101169117510791394
   PubMedGoogle Scholar
• ProvanDWeatherallDRed cells II: acquired anaemias and polycythaemiaLancet200035592111260126810770319
   PubMed Web of Science ®Google Scholar
• RingroseJHvan SolingeWWMohammedSHighly efficient depletion strategy for the two most abundant erythrocyte soluble proteins improves proteome coverage dramaticallyJ Proteome Res2008773060306318494517
   PubMed Web of Science ®Google Scholar
• Roux-DalvaiFGonzalez de PeredoASimoCExtensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometryMol Cell Proteomics20087112254226918614565
   PubMed Web of Science ®Google Scholar
• WangMYouJBemisKGTegelerTJBrownDPLabel-free mass spectrometry-based protein quantification technologies in proteomic analysisBrief Funct Genomics Proteomic200875329339
   Google Scholar
• SuzukiRShimodairaHPvclust: an R package for assessing the uncertainty in hierarchical clusteringBioinformatics200622121540154216595560
   PubMed Web of Science ®Google Scholar
• BouyssieDGonzalez de PeredoAMoutonEMascot file parsing and quantification (MFPaQ), a new software to parse, validate, and quantify proteomics data generated by ICAT and SILAC mass spectrometric analyses: application to the proteomics study of membrane proteins from primary human endothelial cellsMol Cell Proteomics2007691621163717533220
   PubMedGoogle Scholar
• Mouton-BarbosaERoux-DalvaiFBouyssieDIn-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantificationMol Cell Proteomics2010951006102120093276
   PubMedGoogle Scholar
• Jimenez-MarinACollado-RomeroMRamirez-BooMArceCGarridoJJBiological pathway analysis by ArrayUnlock and ingenuity pathway analysisBMC Proc20093suppl 4S619615119
   PubMedGoogle Scholar
• KalfaTAPushkaranSMohandasNRac GTPases regulate the morphology and deformability of the erythrocyte cytoskeletonBlood2006108123637364516882712
   PubMedGoogle Scholar
• WangLYangLFilippiMDWilliamsDAZhengYGenetic deletion of Cdc42GAP reveals a role of Cdc42 in erythropoiesis and hematopoietic stem/progenitor cell survival, adhesion, and engraftmentBlood200610719810516174757
   PubMedGoogle Scholar
• ShiMZabetianCPHancockAMSignificance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson’s diseaseNeurosci Lett20104801788220540987
   PubMed Web of Science ®Google Scholar
• BonifatiVRizzuPvan BarenMJMutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonismScience2003299560425625912446870
   PubMed Web of Science ®Google Scholar
• SpillantiniMGCrowtherRAJakesRHasegawaMGoedertMalpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodiesProc Natl Acad Sci U S A19989511646964739600990
   PubMed Web of Science ®Google Scholar
• ProhaskaRSibonOCRudnickiDDBrain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegenerationNeurobiol Dis201246360762422426390
   PubMed Web of Science ®Google Scholar
• AbrahamSSoundararajanCCVivekanandhanSBehariMErythrocyte antioxidant enzymes in Parkinson’s diseaseIndian J Med Res2005121211111515756044
   PubMedGoogle Scholar
• VillanuevaJLawlorKToledo-CrowRTempstPAutomated serum peptide profilingNat Protoc20061288089117406321
   PubMedGoogle Scholar